Literature DB >> 9715472

[Hyperkinetic syndrome (attention deficit-/hyperactivity disorder) in adulthood].

K H Krause1, J Krause, G E Trott.   

Abstract

The clinical picture of adult hyperkinetic syndrome (HKS) or attention deficit/hyperactivity disorder is nearly unknown in Germany. It can be estimated, that approximately one third of affected children also show symptoms as adults. In the combined type of the syndrome symptoms of inattention as well as of hyperactivity and impulsivity are present, a predominantly inattentive or hyperactive-impulsive type is possible. Retrospective diagnosis of HKS in childhood can be difficult. Disorganization, emotional disturbances and stress intolerance are common in adults with HKS as well as residual symptoms of learning disorders like dyslexia, dyscalculia and dysgraphia. In differential diagnosis especially affective, anxiety and antisocial personality disorders have to be considered, for which on the other side a frequent comorbidity with HKS is known. There is strong evidence for genetic transmission. Neurobiological findings revealed dysregulation of neurotransmitters. For treatment stimulants as pemoline and methamphetamin are effective, in addition tricyclic antidepressants or beta blockers; positive effects are probable for moclobemide, bupropion, fluoxetine and venlafaxine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715472     DOI: 10.1007/s001150050311

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  8 in total

1.  [Military service with adult attention deficit hyperactivity disorder: adaptability of affected soldiers on active service in the German Armed Forces].

Authors:  P Zimmermann; M Jenuwein; K H Biesold; A Heinz; A Ströhle
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

Review 2.  [The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness].

Authors:  M Schlander; G-E Trott; O Schwarz
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

3.  [Attention deficit-hyperactivity disorder (ADHD) and comorbid mental disorders : ADHD-specific self-rating scales in differential diagnostics].

Authors:  M Paucke; T Stark; C Exner; C Kallweit; U Hegerl; M Strauß
Journal:  Nervenarzt       Date:  2018-11       Impact factor: 1.214

4.  Neural correlates (ERP/fMRI) of voluntary selection in adult ADHD patients.

Authors:  Susanne Karch; Tobias Thalmeier; Jürgen Lutz; Anja Cerovecki; Markus Opgen-Rhein; Bettina Hock; Gregor Leicht; Kristina Hennig-Fast; Thomas Meindl; Michael Riedel; Christoph Mulert; Oliver Pogarell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11-12       Impact factor: 5.270

5.  Hippocampus and amygdala morphology in adults with attention-deficit hyperactivity disorder.

Authors:  Evgeniy Perlov; Alexandra Philipsen; Ludger Tebartz van Elst; Dieter Ebert; Juergen Henning; Simon Maier; Emanuel Bubl; Bernd Hesslinger
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

6.  [Attention deficit hyperactivity disorder in adults. An overview].

Authors:  E Sobanski; B Alm
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 7.  [Attention deficit and hyperactivity disorder: what is currently known and its significance for ENT specialists].

Authors:  C Schwemmle; U Schwemmle; M Ptok
Journal:  HNO       Date:  2007-07       Impact factor: 1.330

8.  Psychological Effects of the COVID-19 Imposed Lockdown on Adults with Attention Deficit/Hyperactivity Disorder: Cross-Sectional Survey Study.

Authors:  Marios Adamou; Tim Fullen; Karl Abbott; Claire Smith; Nazmeen Galab; Isobel Mackintosh; Deborah Lowe
Journal:  JMIR Form Res       Date:  2020-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.